Efficacy and Safety of a Novel Gummy Formulation for the Management of Cough in Adults: Double Blind, Randomized, Placebo-Controlled Trial
Open Access
- 28 March 2022
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 12 (7), 3427
- https://doi.org/10.3390/app12073427
Abstract
The cough is one of the most common medical complaints affecting the general population. It is well known that persisting cough negatively affects subjects’ quality of life (QoL) and sleep quality. The aim of the current double blind, randomized, placebo-controlled, pilot study was to assess the effectiveness of a novel medical device in gummy format in reducing cough and improving QoL in adult subjects with acute persisting cough. Forty subjects were enrolled and randomized into two arms according to the treatment. Both the investigational product (IP) and placebo were administered orally, three times per day for 10 consecutive days. Cough symptoms and severity were measured by the Cough Clinical Score (CCS) consisting of a 6-point Likert scale, Leicester Cough Questionnaire (LCQ) and cough severity visual analogue scale (VAS). QoL was rated using the SF-36 (short form) questionnaire. Significant improvements were seen both in the daytime and nighttime cough score after 5 days and at the end of treatment in the IP group but not in those subjects taking the placebo. QoL and sleep disturbances were ameliorated significantly in the IP group only. In conclusion, IP was found safe, well-tolerated and effective in the management of persisting cough in adults.This publication has 25 references indexed in Scilit:
- Ethnobotanical and scientific aspects of Malva sylvestris L.: a millennial herbal medicineJournal of Pharmacy and Pharmacology, 2011
- Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory virusesPhytomedicine, 2011
- Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitisActa Paediatrica, 2010
- Predicting the duration of symptoms in lower respiratory tract infectionBritish Journal of General Practice, 2008
- In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630Phytomedicine, 2007
- Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitroPhytomedicine, 2007
- Extract of Pelargonium sidoides (EPs® 7630) inhibits the interactions of group A-streptococci and host epithelia in vitroPhytomedicine, 2007
- A new approach to pharmacological effects on ciliary beat frequency in cell cultures—exemplary measurements under Pelargonium sidoides extract (EPs 7630)Phytomedicine, 2005
- Evidence for Bioadhesive Effects of Polysaccharides and Polysaccharide-Containing Herbs in an ex vivo Bioadhesion Assay on Buccal MembranesPlanta Medica, 2000
- Antibacterial Activity of Extracts and Constituents ofPelargonium sidoidesandPelargonium reniformePlanta Medica, 1997